{"id":18563,"date":"2020-12-01T20:26:07","date_gmt":"2020-12-01T19:26:07","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=18563"},"modified":"2020-12-01T20:26:08","modified_gmt":"2020-12-01T19:26:08","slug":"europese-commissie-publiceert-pharmaceutical-strategy","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/","title":{"rendered":"Europese Commissie publiceert Pharmaceutical Strategy"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In het persbericht bij de recent gepubliceerde Europese Pharmaceutical Strategy, steekt de Europese Commissie de loftrompet op de bijdrage van biotech aan gezondheid: of het nu om behandelingen tegen chronische ziektes als diabetes en hepatitis C gaat, vaccins tegen HPV of Ebola, gepersonaliseerde behandelingen tegen kanker en de opkomst van cel- en gentherapie\u00ebn. Tegelijkertijd wil de Europese Commissie er ook voor zorgen dat nieuwe innovaties blijven komen en ook beschikbaar en betaalbaar zijn in heel Europa. De Pharmaceutical Strategy probeert hier een mouw aan te passen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Zo is in de strategie onder andere aandacht voor de ontwikkeling van en de toegang tot nieuwe geneesmiddelen voor indicaties waar nu nog geen behandeling voorhanden is of waar de ontwikkeling stokt, zoals bij antibiotica. Verder wil de Europese Commissie breder inzetten op digitale infrastructuren, uitwisseling van data en de inzet van andere technologie\u00ebn en innovatieve toepassingen die bijdragen aan snellere en betere geneesmiddelenontwikkeling. Ook is er aandacht voor het competitiever maken van Europese ontwikkelaars, bijvoorbeeld door de inzet op meer financieringsmogelijkheden en regulatoire flexibiliteit. Tenslotte wil de Europese onderzoek ook meer geld voor onderzoek naar zeldzame ziekten, waar nu nog ruimte voor verbetering is, en samenwerking tussen alle betrokken partijen stimuleren. HollandBIO is blij om deze punten, die goed aansluiten bij onze inbreng bij de consultatie eerder dit jaar, terug te zien in de strategie. Onze inbreng is samen met alle ingestuurde reacties terug te vinden op de <strong><a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/12421-Pharmaceutical-Strategy-Timely-patient-access-to-affordable-medicines\/public-consultation\">website<\/a> <\/strong>van de Europese Commissie.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Het persbericht rond de publicatie lees je <a href=\"https:\/\/ec.europa.eu\/health\/sites\/health\/files\/human-use\/docs\/pharmastrategy_com2020-761_en.pdf\"><strong>hier<\/strong><\/a>, de hele Pharmaceutical Strategy is <a href=\"https:\/\/ec.europa.eu\/health\/human-use\/strategy_en\"><strong>hier te lezen<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In het persbericht bij de recent gepubliceerde Europese Pharmaceutical Strategy, steekt de Europese Commissie de loftrompet op de bijdrage van biotech aan gezondheid: of het nu om behandelingen tegen chronische ziektes als diabetes en hepatitis C gaat, vaccins tegen HPV of Ebola, gepersonaliseerde behandelingen tegen kanker en de opkomst van cel- en gentherapie\u00ebn. Tegelijkertijd wil [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59,39],"tags":[],"class_list":["post-18563","post","type-post","status-publish","format-standard","hentry","category-gezondheid-op-maat","category-gezondheid"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Europese Commissie publiceert Pharmaceutical Strategy - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europese Commissie publiceert Pharmaceutical Strategy - hollandbio\" \/>\n<meta property=\"og:description\" content=\"In het persbericht bij de recent gepubliceerde Europese Pharmaceutical Strategy, steekt de Europese Commissie de loftrompet op de bijdrage van biotech aan gezondheid: of het nu om behandelingen tegen chronische ziektes als diabetes en hepatitis C gaat, vaccins tegen HPV of Ebola, gepersonaliseerde behandelingen tegen kanker en de opkomst van cel- en gentherapie\u00ebn. Tegelijkertijd wil [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T19:26:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-01T19:26:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"Europese Commissie publiceert Pharmaceutical Strategy\",\"datePublished\":\"2020-12-01T19:26:07+00:00\",\"dateModified\":\"2020-12-01T19:26:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/\"},\"wordCount\":263,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Gezondheid op maat\",\"Gezondheid\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/\",\"name\":\"Europese Commissie publiceert Pharmaceutical Strategy - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2020-12-01T19:26:07+00:00\",\"dateModified\":\"2020-12-01T19:26:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/europese-commissie-publiceert-pharmaceutical-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europese Commissie publiceert Pharmaceutical Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Europese Commissie publiceert Pharmaceutical Strategy - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/","og_locale":"en_US","og_type":"article","og_title":"Europese Commissie publiceert Pharmaceutical Strategy - hollandbio","og_description":"In het persbericht bij de recent gepubliceerde Europese Pharmaceutical Strategy, steekt de Europese Commissie de loftrompet op de bijdrage van biotech aan gezondheid: of het nu om behandelingen tegen chronische ziektes als diabetes en hepatitis C gaat, vaccins tegen HPV of Ebola, gepersonaliseerde behandelingen tegen kanker en de opkomst van cel- en gentherapie\u00ebn. Tegelijkertijd wil [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/","og_site_name":"hollandbio","article_published_time":"2020-12-01T19:26:07+00:00","article_modified_time":"2020-12-01T19:26:08+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"Europese Commissie publiceert Pharmaceutical Strategy","datePublished":"2020-12-01T19:26:07+00:00","dateModified":"2020-12-01T19:26:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/"},"wordCount":263,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Gezondheid op maat","Gezondheid"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/","name":"Europese Commissie publiceert Pharmaceutical Strategy - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2020-12-01T19:26:07+00:00","dateModified":"2020-12-01T19:26:08+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/europese-commissie-publiceert-pharmaceutical-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Europese Commissie publiceert Pharmaceutical Strategy"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=18563"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18563\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=18563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=18563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=18563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}